Primary cutaneous Hodgkin-like polymorphic post-transplant lymphoproliferative disorder.

Hodgkin-like PTLD dermatopathology non-healing ulcer post-transplant lymphoproliferative disorder transplant recipient

Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
May 2019
Historique:
received: 22 06 2018
revised: 28 12 2018
accepted: 14 01 2019
pubmed: 24 1 2019
medline: 14 8 2019
entrez: 24 1 2019
Statut: ppublish

Résumé

Post-transplant lymphoproliferative disorder (PTLD) is an uncommon complication after solid-organ transplants and hematopoietic stem cell transplants. Isolated involvement of the skin without systemic involvement in PTLD is extremely rare. Primary cutaneous PTLD is generally categorized as either cutaneous T-cell lymphoma or cutaneous B-cell lymphoma, with variable Epstein-Barr virus (EBV) positivity. Herein, we describe an exceedingly uncommon case of a primary cutaneous Hodgkin-like polymorphic PTLD. A man in his 60s, with a history of kidney transplant, presented with a 5-week history of two indurated plaques. Clinical, histologic and immunohistochemical findings were consistent with primary cutaneous Hodgkin-like polymorphic PTLD. Reduction in immunosuppression led to resolution of his lesions. This case highlights a rare case of primary cutaneous Hodgkin-like PTLD and increases awareness of this uncommon post-transplant complication. It also underscores the importance of collaboration between dermatology, hematology, dermatopathology and hematopathology in order to diagnose challenging cases.

Identifiants

pubmed: 30672006
doi: 10.1111/cup.13427
doi:

Types de publication

Case Reports

Langues

eng

Pagination

358-362

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Carly Dunn (C)

Department of Dermatology, Baylor College of Medicine, Houston, Texas.

Harrison P Nguyen (HP)

Department of Dermatology, Baylor College of Medicine, Houston, Texas.

Viraat Patel (V)

Department of Dermatology, Baylor College of Medicine, Houston, Texas.

Heather S Barker (HS)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.

A Hafeez Diwan (AH)

Department of Dermatology, Baylor College of Medicine, Houston, Texas.
Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.

Marwan Yared (M)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.

Tarek Elghetany (T)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Department of Pathology, Texas Children's Hospital, Houston, Texas.

Alejandro Restrepo (A)

Department of Internal Medicine, Section of Infectious Disease, Baylor College of Medicine, Houston, Texas.

Harry Dao (H)

Department of Dermatology, Baylor College of Medicine, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH